APA

Stempel D. A., Durcannin-Robbins J. F., Hedblom E. C., Woolf R., Sturm L. L. & Stempl A. B. (19960412). Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Chicago

Stempel D A, Durcannin-Robbins J F, Hedblom E C, Woolf R, Sturm L L and Stempl A B. 19960412. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Harvard

Stempel D. A., Durcannin-Robbins J. F., Hedblom E. C., Woolf R., Sturm L. L. and Stempl A. B. (19960412). Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

MLA

Stempel D A, Durcannin-Robbins J F, Hedblom E C, Woolf R, Sturm L L and Stempl A B. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 19960412.